hydroxyurea has been researched along with Gasser Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, M | 1 |
| Kita, A | 1 |
| Leach, J | 1 |
| Rounsevell, R | 1 |
| Huang, JN | 1 |
| Moake, J | 1 |
| Ware, RE | 1 |
| Fletcher, DA | 1 |
| Lam, WA | 1 |
| Ohashi, N | 1 |
| Yonemura, K | 1 |
| Sugiura, T | 1 |
| Isozaki, T | 1 |
| Togawa, A | 1 |
| Fujigaki, Y | 1 |
| Yamamoto, T | 1 |
| Hishida, A | 1 |
| Al-Zahrani, H | 1 |
| Gupta, V | 1 |
| Minden, MD | 1 |
| Messner, HA | 1 |
| Lipton, JH | 2 |
| Minden, M | 1 |
| Shammas, F | 1 |
| Meyer, P | 1 |
| Heikkila, R | 1 |
| Apeland, T | 1 |
| Gøransson, L | 1 |
| Berland, J | 1 |
| Kjellevold, K | 1 |
1 review available for hydroxyurea and Gasser Syndrome
| Article | Year |
|---|---|
Vascular events associated with alpha interferon therapy.
Topics: Adult; Antineoplastic Agents; Fatal Outcome; Female; Foot Ulcer; Gangrene; Hemolytic-Uremic Syndrome | 2003 |
4 other studies available for hydroxyurea and Gasser Syndrome
| Article | Year |
|---|---|
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology.
Topics: Anemia, Sickle Cell; Eptifibatide; Hematologic Diseases; Hemolytic-Uremic Syndrome; Hemorheology; Hu | 2012 |
Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hemolysis; Hemolytic-Uremic Syndrome; Humans; | 2003 |
CML may not be part of HUS.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Disease Progression; Gr | 1995 |
Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea.
Topics: Antineoplastic Agents; Female; Hemolytic-Uremic Syndrome; Humans; Hydroxyurea; Leukemia, Myelogenous | 1997 |